Skip to content
★ Sign in to follow
JA

James Alecxih

ViewRay, Inc.Nevro Corp
Total declarations
3
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 28 Oct 2019 for ViewRay, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

James Alecxih: trading record in brief

James Alecxih has filed trades across 2 companies (mainly through SEC (Form 4)), most often in ViewRay, Inc. and Nevro Corp. Between 12 December 2017 and 24 October 2019, the trades on record add up to 3 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 28 October 2019, the filings show a share grant in ViewRay, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to James Alecxih

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ◆
    Chief Commercial OfficerExecutivesViewRay, Inc.
    0SEC
    240,000 shares0Common StockSEC:0001209191-19-054261:0
  • ◆
    Chief Commercial OfficerExecutivesViewRay, Inc.
    0SEC
    38,371 shares0Common StockSEC:0001209191-19-016561:0
  • ◆
    Vice President, SalesExecutivesNevro Corp
    0SEC
    12,000 shares0Common StockSEC:0001140361-17-046195:0

3 of 3 declarations